Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPKAPK2 | P49137 | 12/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6787349 | 1.00 | MAPKAPK2 (0.35) | MAPKAPK2 | |
| SCHEMBL6792648 | 0.91 | CSNK1A1 (0.36) | MAPKAPK2 | |
| SCHEMBL6792642 | 0.91 | CSNK1A1 (0.36) | MAPKAPK2 | |
| SCHEMBL6793661 | 0.89 | CNR1 (0.33) | MAPKAPK2 | |
| SCHEMBL6793667 | 0.89 | CNR1 (0.33) | MAPKAPK2 | |
| Hydrochloric Acid SCHEMBL6793080 | 0.88 | CNR1 (0.32) | MAPKAPK2 | |
| Hydrochloric Acid SCHEMBL6793079 | 0.88 | CNR1 (0.32) | MAPKAPK2 | |
| SCHEMBL6791923 | 0.88 | MAPKAPK2 (0.33) | MAPKAPK2 | |
| SCHEMBL6791922 | 0.88 | MAPKAPK2 (0.33) | MAPKAPK2 | |
| SCHEMBL6792165 | 0.88 | PARP1 (0.34) | MAPKAPK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | PHARMACIA CORPORATION | 2004-07-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127492-A1 | Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2 | MKNK2, MAPKAPK2, MAP3K2 | MAPKAPK2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.